CHINA / DIPLOMACY By Global Times Published: Jan 27, 2021 06:54 PM
A nurse administers the second dose of COVID-19 vaccine to a driver of the Shenzhen Bus Group Co., Ltd. at the health service center of the Xiameilin community in Futian District, Shenzhen, south China s Guangdong Province, Jan. 24, 2021. The Shenzhen Bus Group Co., Ltd. encourages its employees to receive COVID-19 vaccines. (Xinhua/Mao Siqian)
A local volunteer in Peru participating in Chinese firm Sinopharm s COVID-19 vaccine clinical trials, who died of COVID-19 pneumonia, received a placebo, not the vaccine. A source close to Sinopharm told the Global Times there is no evidence that the death was related to the company s vaccine.